- Record: found
- Abstract: not found
- Article: not found
AURELIA: A randomized phase III trial evaluating bevacizumab (BEV) plus chemotherapy (CT) for platinum (PT)-resistant recurrent ovarian cancer (OC).
Eric Pujade-Lauraine, Felix Hilpert, Béatrice Weber, Alexander Reuss, Andrés Poveda, Gunnar Kristensen, Roberto Sorio, Ignace B. Vergote, Petronella O. Witteveen, Aristotelis Bamias, Deolinda Pereira, Pauline Wimberger, Ana Oaknin, Mansoor Mirza, Philippe Follana, David T. Bollag, Isabelle Ray-Coquard, E Pujade-Lauraine, F Hilpert, B WEBER, A Reuss, A. Poveda, G Kristensen, R Sorio, IB Vergote, P. Witteveen, A Bamias, B Weber-Hamann, A. Poveda, I Vergote, P. O. Witteveen, D Pereira, P Wimberger, A. Oaknin
2012
Read this article at
ScienceOpenPublisher
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.